The activated partial thromboplastin time may not reveal even severe fibrinogen deficiency

Artikel in diesem Heft

1. Frontmatter
2. Editorial
3. Machine learning and coagulation testing: the next big thing in hemostasis investigations?
4. Reviews
5. Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors
6. The underestimated issue of non-reproducible cardiac troponin I and T results: case series and systematic review of the literature
7. Opinion Paper
8. Benefits, limitations and controversies on patient-based real-time quality control (PBRTQC) and the evidence behind the practice
9. Genetics and Molecular Diagnostics
10. ctDNA from body fluids is an adequate source for EGFR biomarker testing in advanced lung adenocarcinoma
11. General Clinical Chemistry and Laboratory Medicine
12. Incidence, characteristics and outcomes among inpatient, outpatient and emergency department with reported high critical serum potassium values
13. Clinical usefulness of drug-laboratory test interaction alerts: a multicentre survey
14. Integrating quality assurance in autoimmunity: the changing face of the automated ANA IIF test
15. Plasma thiol/disulphide homeostasis changes in patients with restless legs syndrome
16. Reference Values and Biological Variations
17. High-resolution pediatric reference intervals for 15 biochemical analytes described using fractional polynomials
18. Continuous reference intervals for leukocyte telomere length in children: the method matters
19. Hematology and Coagulation
20. Using machine learning to identify clotted specimens in coagulation testing
21. Cardiovascular Diseases
22. Long term pronostic value of suPAR in chronic heart failure: reclassification of patients with low MAGGIC score
23. Infectious Diseases
24. Monocyte distribution width (MDW) parameter as a sepsis indicator in intensive care units
25. A low level of CD16^pos monocytes in SARS-CoV-2 infected patients is a marker of severity
26. Thrombin generation in patients with COVID-19 with and without thromboprophylaxis
27. Corrigendum
28. Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia
29. Letters to the Editors
30. Additional approaches for identifying non-reproducible cardiac troponin results
31. Paediatric reference intervals for ionised calcium – a data mining approach
32. A case of interference in testosterone, DHEA-S and progesterone measurements by second generation immunoassays
33. Lack of cross-reactivity between anti-A IgG isoagglutinins and anti-SARS-CoV-2 IgG antibodies
34. Artefactual bands on urine protein immunofixation gels
35. A case of methaemoglobinaemia interference on the WDF channel on Sysmex XN-Series analysers
36. Soluble fms-like tyrosine kinase-1: a potential early predictor of respiratory failure in COVID-19 patients
37. Serendipitous detection of α₁-antitrypsin deficiency: a single institution’s experience over a 32 month period
38. The activated partial thromboplastin time may not reveal even severe fibrinogen deficiency
39. Influence of C-reactive protein on thrombin generation assay
40. Inappropriate extrapolations abound in fecal microbiota research